Assignee
DOSE MEDICAL CORP
US·14 granted patents·11 pending applications·375 citations·filing 2010–2024
Top patents by PatentIndex Score
25 records- 0198US12208034B2Implants with controlled drug delivery features and methods of using sameDOSE MEDICAL CORP·Filed 2021·Granted Jan 28, 2025·7 cites·17 claims
- 0298US12201557B2Drug eluting ocular implant and method of treating an ocular disorderDOSE MEDICAL CORP·Filed 2022·Granted Jan 21, 2025·8 cites·20 claims
- 0398US12201555B2Drug eluting ocular implantDOSE MEDICAL CORP·Filed 2021·Granted Jan 21, 2025·7 cites·20 claims
- 0498US9789001B2Ocular implant with therapeutic agents and methods thereofDOSE MEDICAL CORP·Filed 2015·Granted Oct 17, 2017·39 cites·15 claims
- 0597US10813789B2Drug eluting ocular implantDOSE MEDICAL CORP·Filed 2017·Granted Oct 27, 2020·38 cites·11 claims
- 0696US11426306B2Implants with controlled drug delivery features and methods of using sameDOSE MEDICAL CORP·Filed 2019·Granted Aug 30, 2022·24 cites·19 claims
- 0796US11253394B2Controlled drug delivery ocular implants and methods of using sameDOSE MEDICAL CORP·Filed 2018·Granted Feb 22, 2022·26 cites·19 claims
- 0896US8348877B2Ocular implant with therapeutic agents and methods thereofDOSE MEDICAL CORP·Filed 2010·Granted Jan 8, 2013·69 cites·20 claims
- 0995US10206813B2Implants with controlled drug delivery features and methods of using sameDOSE MEDICAL CORP·Filed 2014·Granted Feb 19, 2019·44 cites·23 claims
- 1095US9603738B2Implants with controlled drug delivery features and methods of using sameDOSE MEDICAL CORP·Filed 2014·Granted Mar 28, 2017·44 cites·8 claims
- 1195US9066782B2Ocular implant with therapeutic agents and methods thereofDOSE MEDICAL CORP·Filed 2012·Granted Jun 30, 2015·63 cites·17 claims
- 1292US11383006B2Bioerodible cross-linked hydrogel implants and related methods of useDOSE MEDICAL CORP·Filed 2020·Granted Jul 12, 2022·5 cites·20 claims
- 1378US11883525B2Bioerodible polyester polymer axitinib ocular implants and related methods of useDOSE MEDICAL CORP·Filed 2020·Granted Jan 30, 2024·1 cites·13 claims
- 1478US2025041485A1Bioerodible cross-linked hydrogel implants and related methods of useDOSE MEDICAL CORP·Filed 2024·Application pending·0 cites
- 1575US12151048B2Bioerodible cross-linked hydrogel implants and related methods of useDOSE MEDICAL CORP·Filed 2022·Granted Nov 26, 2024·0 cites·16 claims
- 1669US2024065887A1Drug delivery implants as intraocular drug depots and methods of using sameDOSE MEDICAL CORP·Filed 2023·Application pending·0 cites
- 1769US2024165017A1Bioerodible polyester polymer axitinib ocular implants and related methods of useDOSE MEDICAL CORP·Filed 2024·Application pending·0 cites
- 1868US2022313486A1Bioresorbable ocular drug delivery deviceDOSE MEDICAL CORP·Filed 2022·Application pending·0 cites
- 1966US2018161205A1Ocular implant with therapeutic agents and methods thereofDOSE MEDICAL CORP·Filed 2017·Application pending·0 cites
- 2060US2018021170A1Implants with controlled drug delivery features and methods of using sameDOSE MEDICAL CORP·Filed 2017·Application pending·0 cites
- 2159US2017135857A1Drug eluting ocular implant with internal plugDOSE MEDICAL CORP·Filed 2017·Application pending·0 cites
- 2253US2015342875A1Implants with controlled drug delivery features and methods of using sameDOSE MEDICAL CORP·Filed 2015·Application pending·0 cites
- 2351US2018028361A1Uveoscleral drug delivery implant and methods for implanting the sameDOSE MEDICAL CORP·Filed 2017·Application pending·0 cites
- 2449US2018333296A1Drug delivery implants as intraocular drug depots and methods of using sameDOSE MEDICAL CORP·Filed 2016·Application pending·0 cites
- 2548US2020375891A1Bioerodible cross-linked hydrogel implants and related methods of useDOSE MEDICAL CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DOSE MEDICAL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →